Company Profile
J. B. Chemicals & Pharmaceuticals manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and globally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium.
Its portfolio also includes nifedipine, atenolol, and cilnidipine, and ciprofloxacin, cetirizine, and meclizine HCI, as well as dosage forms, such as tablets, capsules, liquids, gels, lozenges, creams, injectables, powder, cold rubs, eye drops, and troches
Soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. Additionally, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services.
It provides its products to gastroenterology, anti-infectives, wound care, neonatology and pediatrics, genecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Incorporated in 1976, Chemicals & Pharmaceuticals is headquartered in Mumbai, India.